High expression of IDO inhibits the activation of APC and reduces antigen presentation; at the same time, IDO can also catalyze the degradation of tryptophan to kynurenine, damaging the activation of CD8+ T cells, and inhibiting their anti-tumor ability by activating regulatory T cells (42, 43). This evidence concerns the gene IDO1 and neoplasm.